Janux Therapeutics, Inc. - JANX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$878.3M
QoQ value delta ($000)
-$708.6M (-44.66%)
Implied price effect (QoQ)
-43.43%
Shares
Total shares
63,536,244
QoQ shares delta
-1,406,024 (-2.17%)
Total shares held by funds (by quarter)

Market chart (JANX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 7 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
RA CAPITAL MANAGEMENT, L.P. 154,417 11,189,693 1.58%
JANUS HENDERSON GROUP PLC 73,850 5,350,453 0.03%
BlackRock, Inc. 56,306 4,080,200 0.0%
STATE STREET CORP 53,184 3,853,951 0.0%
FMR LLC 48,470 3,512,384 0.0%
VANGUARD GROUP INC 40,108 2,906,386 0.0%
Prosight Management, LP 33,016 2,392,523 6.82%
ORBIMED ADVISORS LLC 26,971 1,954,426 0.55%
TCG Crossover Management, LLC 24,696 1,789,617 0.82%
WELLINGTON MANAGEMENT GROUP LLP 22,220 1,610,186 0.0%
Alyeska Investment Group, L.P. 17,955 1,301,089 0.05%
CITADEL ADVISORS LLC 17,049 1,235,444 0.0%
GEODE CAPITAL MANAGEMENT, LLC 15,370 1,113,582 0.0%
GOLDMAN SACHS GROUP INC 14,816 1,073,656 0.0%
Woodline Partners LP 14,175 1,027,221 0.05%
Logos Global Management LP 13,800 1,000,000 0.83%
Point72 Asset Management, L.P. 13,273 961,819 0.01%
READYSTATE ASSET MANAGEMENT LP 12,225 885,895 0.5%
BALYASNY ASSET MANAGEMENT L.P. 12,220 885,551 0.02%
Caption Management, LLC 10,798 782,500 0.07%
PRICE T ROWE ASSOCIATES INC /MD/ 10,274 744,466 0.0%
BANK OF AMERICA CORP /DE/ 10,188 738,330 0.0%
Cormorant Asset Management, LP 8,970 650,000 0.41%
JANE STREET GROUP, LLC 8,618 624,533 0.0%
MORGAN STANLEY 8,533 618,385 0.0%